Biospecifics Technologies (BSTC) Reports Q4 EPS of $0.36
Tweet
Share
E-mailGet Alerts BSTC Hot Sheet
Price: $88.53 --0%
Financial Fact:
Operating income (loss): 4.73M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Operating income (loss): 4.73M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Biospecifics Technologies (NASDAQ: BSTC) reported Q4 EPS of $0.36, versus $27.00 reported last year. Revenue for the quarter came in at $6.1 million, versus $4.6 million reported last year.
For earnings history and earnings-related data on Biospecifics Technologies (BSTC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
